Two-Year TAXUS-IV Stent Data Show Slight Increase In Thrombosis
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific's Taxus drug-eluting stent is associated with slightly greater long-term thrombosis than the bare-metal Express in the TAXUS-IV study